Testing a vaccine to prevent stomach flu in healthy adults
Part of Infections clinical trials.
This trial tests an investigational vaccine called INT101 to see if it can prevent norovirus, a common cause of stomach flu (vomiting and diarrhea). It is given to healthy adults to check its safety and how well it works before moving to larger studies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 19 and 48 years old.
- You have a body mass index (BMI) between 18 and 30.
- You are in good general health, with no ongoing medical conditions like asthma, diabetes, or epilepsy.
- You agree to use effective birth control (if you can become pregnant or father a child).
- You have not had stomach illness (diarrhea, vomiting) in the last 2 weeks.
- You have not had certain vaccines or medications that affect your immune system recently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a single dose of a new medication (NM-101) in healthy male volunteers to see how the body handles it and if it's safe. It is a phase 1 study that requires you to be in good health and have no major medical conditions.
This trial tests an investigational medicine called CDI-988 to see if it can prevent or treat norovirus infection. Healthy adults will be intentionally exposed to a mild norovirus strain to see how the medicine works.
This first-in-human study tests the safety of a new medicine called VNT-101. Healthy adults aged 18 to 59 who do not smoke and have no major health problems may be able to join. The goal is to see how the body handles the drug and if it is safe.
This Phase 1 study tests an investigational influenza (flu) approach in a carefully selected group of healthy adults. It may help researchers understand how the flu challenge works and how well the treatment performs and is tolerated.
This trial is testing a new mRNA-based flu vaccine in healthy adults. It aims to see if the vaccine is safe and effective at preventing influenza.
This trial tests how the body reacts to a specific flu virus (pH1N1) in a controlled setting. Healthy volunteers are exposed to the virus to help researchers understand the infection and test treatments. You will be monitored closely and given antiviral medication if needed.
Hear when a new Norovirus Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.